These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28091502)

  • 21. Citicoline: pharmacological and clinical review, 2016 update.
    Secades JJ
    Rev Neurol; 2016 Dec; 63(S03):S1-S73. PubMed ID: 28417449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The assessment of the efficacy of citicoline in the early and recovery stages of stroke].
    Shavlovskaya OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(6):93-97. PubMed ID: 28635796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Citicoline: pharmacological and clinical review, 2022 update.
    Secades JJ; Gareri P
    Rev Neurol; 2022 Nov; 75(s05):S1-S89. PubMed ID: 36544369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What's new with neuroprotective agents in stroke?
    Bankhead C
    Drugs R D; 1999 Jan; 1(1):49-51. PubMed ID: 10565987
    [No Abstract]   [Full Text] [Related]  

  • 25. Cholinergic nervous system and glaucoma: From basic science to clinical applications.
    Faiq MA; Wollstein G; Schuman JS; Chan KC
    Prog Retin Eye Res; 2019 Sep; 72():100767. PubMed ID: 31242454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The individual and combined antioxidant effects of citicoline and ethylmethylhydroxypyridini succinas].
    Solovyeva EY; Karneev AN; Chekanov AV; Baranova OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11):78-85. PubMed ID: 28091505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotection and recovery: recent data at the bench on citicoline.
    Hurtado O; Lizasoain I; Moro MÁ
    Stroke; 2011 Jan; 42(1 Suppl):S33-5. PubMed ID: 21164125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study of the effects of vinpocetin on cognitive functions].
    Valikovics A; Csányi A; Németh L
    Ideggyogy Sz; 2012 Mar; 65(3-4):115-20. PubMed ID: 23136730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Citicoline in pre-clinical animal models of stroke: a meta-analysis shows the optimal neuroprotective profile and the missing steps for jumping into a stroke clinical trial.
    Bustamante A; Giralt D; Garcia-Bonilla L; Campos M; Rosell A; Montaner J
    J Neurochem; 2012 Oct; 123(2):217-25. PubMed ID: 22845688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The current state of citicholine in cerebral ischemia].
    Abad-Santos F; Gallego-Sandín S; Novalbos J; Gálvez-Múgica MA
    Rev Neurol; 2000 Apr 1-15; 30(7):663-70. PubMed ID: 10859748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The use of cerepro (choline alfoscerate) in the treatment of outpatients with chronic progressive cerebrovascular disease].
    Kostenko EV; Petrova LV; Artemova IIu; Vdovichenko TV; Ganzhula PA; Ismailov AM; Lisenker LN; Petrov SV; Otcheskaia OV; Rotor LD; Khozova AA; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(3 Pt 1):24-30. PubMed ID: 22677751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives.
    Gareri P; Castagna A; Cotroneo AM; Putignano S; De Sarro G; Bruni AC
    Clin Interv Aging; 2015; 10():1421-9. PubMed ID: 26366063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of citicoline on level of consciousness, serum level of fetuin-A and matrix Gla-protein (MGP) in trauma patients with diffuse axonal injury (DAI) and GCS≤8.
    Shokouhi G; Haghjoo AG; Sattarnezhad N; Asghari M; Sattarnezhad A; Asghari A; Pezeshki A
    Ulus Travma Acil Cerrahi Derg; 2014 Nov; 20(6):410-6. PubMed ID: 25541919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Agentss to improve cerebrovascular circulation and cerebral metabolism--citicoline].
    Miyazaki M
    Nihon Rinsho; 1985 Feb; 43(2):372-5. PubMed ID: 3999407
    [No Abstract]   [Full Text] [Related]  

  • 35. [Citicoline as component of the therapy of postoperative delirium in neurosurgical patients].
    Popugaev KA; Savin IA; Sokolova EIu; Oshorov AV; Kadashev BA; Kalinin PL; Kutin MA
    Anesteziol Reanimatol; 2013; (4):50-4. PubMed ID: 24341043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticonvulsant Effects of Combined Treatment with Citicoline and Valproate on the Model of Acute Generalized Convulsions Induced by Pentylenetetrazole in Wistar Rats.
    Karpova MN; Kuznetsova LV; Zin'kovskii KA; Klishina NV
    Bull Exp Biol Med; 2016 Feb; 160(4):429-31. PubMed ID: 26902360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of mild cognitive impairment: value of citicoline].
    Abad-Santos F; Novalbos-Reina J; Gallego-Sandín S; García AG
    Rev Neurol; 2002 Oct 1-15; 35(7):675-82. PubMed ID: 12389156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late treatment with choline alfoscerate (l-alpha glycerylphosphorylcholine, α-GPC) increases hippocampal neurogenesis and provides protection against seizure-induced neuronal death and cognitive impairment.
    Lee SH; Choi BY; Kim JH; Kho AR; Sohn M; Song HK; Choi HC; Suh SW
    Brain Res; 2017 Jan; 1654(Pt A):66-76. PubMed ID: 27765578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT).
    Zafonte RD; Bagiella E; Ansel BM; Novack TA; Friedewald WT; Hesdorffer DC; Timmons SD; Jallo J; Eisenberg H; Hart T; Ricker JH; Diaz-Arrastia R; Merchant RE; Temkin NR; Melton S; Dikmen SS
    JAMA; 2012 Nov; 308(19):1993-2000. PubMed ID: 23168823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Choline supplements: An update.
    Kansakar U; Trimarco V; Mone P; Varzideh F; Lombardi A; Santulli G
    Front Endocrinol (Lausanne); 2023; 14():1148166. PubMed ID: 36950691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.